missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Lysates
  5. Overexpression Lysates
  6. 18275804

Novus Biologicals™ CCL22/MDC Overexpression Lysate

Codice prodotto. 18275804
Cambia vista
Click to view available options
Quantità:
0.1 mg
Dimensione della confezione:
0.10mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Codice prodotto. Quantità unitSize
18275804 0.1 mg 0.10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso
Codice prodotto. 18275804 Fornitore Novus Biologicals™ N. del fornitore NBL108852
  • ONLINE EXCLUSIVE PRICE
    902.00€
    852.60€ / 0.1mg
    Risparmia 49.40€
    5% Sconto
 Articolo soggetto a restrizioni
Spedizione stimata: 28-08-2026
Aggiungi al carrello
Aggiungi al carrello
Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso

Descrizione

The CCL22/MDC Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.
TRUSTED_SUSTAINABILITY

Specifications

Linea cellulare The lysate was created in HEK293T cells, using plasmid ID RC26578 and based on accession number NM_299. The protein contains a C-terminal DDK tag.
Da utilizzare con (applicazione) Western Blot
Quantità 0.1 mg
Tampone di conservazione RIPA buffer
Purezza Protein
Test di specificità Homo sapiens chemokine (C-C motif) ligand 22 (CCL22), mRNA.
Content And Storage -80°C. Avoid freeze-thaw cycles.
Protein State Native

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.